Cargando…
Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). WHAT IS ADDED BY THIS REPORT? In order to reduce the incidence of COVID-1...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837462/ https://www.ncbi.nlm.nih.gov/pubmed/35186374 http://dx.doi.org/10.46234/ccdcw2022.012 |
_version_ | 1784649914244923392 |
---|---|
author | Wang, Lianhao Wang, Shiyi Zhang, Xiangyu Jia, Zhongwei |
author_facet | Wang, Lianhao Wang, Shiyi Zhang, Xiangyu Jia, Zhongwei |
author_sort | Wang, Lianhao |
collection | PubMed |
description | WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). WHAT IS ADDED BY THIS REPORT? In order to reduce the incidence of COVID-19 to the levels of influenza after restoring normal mobility, the efficacy against infection needs to be increased to 40% and the efficacy against symptomatic disease needs to be increased to 90%. The efficacy against infection has a more important impact compared to efficacy against symptomatic disease or death on the transmission of COVID-19 at the population level. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The population should continue maintaining non-pharmaceutical interventions and minimize international movement to prevent transmission of COVID-19. Furthermore, developing new vaccines or promoting booster vaccinations should be considered to increase efficacy. |
format | Online Article Text |
id | pubmed-8837462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-88374622022-02-18 Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 Wang, Lianhao Wang, Shiyi Zhang, Xiangyu Jia, Zhongwei China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Reducing population mobility and increasing the vaccination rate for severe acute respiratory syndrome coronavirus 2 can decrease the transmission of coronavirus disease 2019 (COVID-19). WHAT IS ADDED BY THIS REPORT? In order to reduce the incidence of COVID-19 to the levels of influenza after restoring normal mobility, the efficacy against infection needs to be increased to 40% and the efficacy against symptomatic disease needs to be increased to 90%. The efficacy against infection has a more important impact compared to efficacy against symptomatic disease or death on the transmission of COVID-19 at the population level. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The population should continue maintaining non-pharmaceutical interventions and minimize international movement to prevent transmission of COVID-19. Furthermore, developing new vaccines or promoting booster vaccinations should be considered to increase efficacy. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022-02-04 /pmc/articles/PMC8837462/ /pubmed/35186374 http://dx.doi.org/10.46234/ccdcw2022.012 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Preplanned Studies Wang, Lianhao Wang, Shiyi Zhang, Xiangyu Jia, Zhongwei Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 |
title | Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 |
title_full | Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 |
title_fullStr | Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 |
title_full_unstemmed | Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 |
title_short | Impact of Regions with COVID-19 Cases on COVID-Zero Regions by Population Mobility — Worldwide, 2021 |
title_sort | impact of regions with covid-19 cases on covid-zero regions by population mobility — worldwide, 2021 |
topic | Preplanned Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837462/ https://www.ncbi.nlm.nih.gov/pubmed/35186374 http://dx.doi.org/10.46234/ccdcw2022.012 |
work_keys_str_mv | AT wanglianhao impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021 AT wangshiyi impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021 AT zhangxiangyu impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021 AT jiazhongwei impactofregionswithcovid19casesoncovidzeroregionsbypopulationmobilityworldwide2021 |